This paper is in the following e-collection/theme issue:

Randomized trials (Editor: G. Eysenbach)* (44) Tx to JMIR Diabetes awaiting author consent (1) Tx to JMIR Formative Res awaiting author consent (1)

Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53740, first published .
Efficacy of Save Medical Corporation (SMC)–01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial

Efficacy of Save Medical Corporation (SMC)–01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial

Efficacy of Save Medical Corporation (SMC)–01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial

Authors of this article:

Nicholas Leung1 Author Orcid Image ;   Kayo Waki2, 3, 4 Author Orcid Image ;   Satoshi Nozoe5 Author Orcid Image ;   Shunpei Enomoto2 Author Orcid Image ;   Ryo Saito2 Author Orcid Image ;   Sakurako Hamagami6 Author Orcid Image ;   Toshimasa Yamauchi4 Author Orcid Image ;   Masaomi Nangaku7 Author Orcid Image ;   Kazuhiko Ohe2, 3 Author Orcid Image ;   Yukiko Onishi8 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
Shotaro Asano @ Save Medical代表 Shotaro Asano @ Save Medical代表 @AsanoShotaroo

弊社が最初に手掛けたアプリ治験（2型糖尿病DTx）に関する論文が公開されました。 試験自体は成功できませんでしたが、成否に関わらず結果を公開し、digitalhealthの進展に（末席からですが）貢献したいという思いがあり東大の脇先生の研究室に解析・執筆して頂きました。 https://t.co/YWMwLxi5ve https://t.co/rmVSPEcodt

1:02 AM · Sep 19, 2024

8
0
長坂 剛 / A10Lab 長坂 剛 / A10Lab @g5goGo

RT @AsanoShotaroo: 弊社が最初に手掛けたアプリ治験（2型糖尿病DTx）に関する論文が公開されました。 試験自体は成功できませんでしたが、成否に関わらず結果を公開し、digitalhealthの進展に（末席からですが）貢献したいという思いがあり東大の脇先生の研究…

4:47 AM · Sep 20, 2024

14
1